Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Kezar Life Sciences Inc
KZRCurrent price
4.70 USD
-0.05 USD (-1.05%)
Last closed
4.58 USD
Company
www.kezarlifesciences.com
ISIN
US49372L1008
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
34 702 552 USD
Yield for 12 month
-43.90 %
1Y
3Y
5Y
10Y
15Y
KZR
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California. Address: 4000 Shoreline Court, South San Francisco, CA, United States, 94080
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
12.50 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+7 000 000 USD
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
+5 934 000 USD
Current Quarter
–
Last Quarter
–
Key Figures KZR
1 year
3 years
5 years
10 years
EBITDA
-88 095 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-30.45 %
PEG Ratio
–
Return On Equity TTM
-55.00 %
Wall Street Target Price
12.50 USD
Revenue TTM
–
Book Value
16.01 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-65 742 000 USD
Earnings per share
-12.07 USD
Diluted Eps TTM
-12.07 USD
Most Recent Quarter
IV 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics KZR
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History KZR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:10
Payout Ratio TTM
–
Last Split Date
30.10.2024
Stock Valuation KZR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
6.03
Enterprise Value EBITDA
0.060
Price Book MRQ
0.30
Financials KZR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators KZR
For 52 weeks
3.62 USD
9.18 USD
50 Day MA
5.29 USD
Shares Short Prior Month
60 447
200 Day MA
6.35 USD
Short Ratio
2.09
Shares Short
60 263
Short Percent
0.84 %
BeatStart